Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 6
2004 7
2005 2
2006 2
2007 2
2008 7
2009 3
2010 3
2011 2
2012 2
2013 2
2014 2
2016 2
2017 2
2018 2
2019 2
2020 3
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
Carlson AP, Hänggi D, Wong GK, Etminan N, Mayer SA, Aldrich F, Diringer MN, Schmutzhard E, Faleck HJ, Ng D, Saville BR, Bleck T, Grubb R Jr, Miller M, Suarez JI, Proskin HM, Macdonald RL; NEWTON Investigators. Carlson AP, et al. Among authors: proskin hm. Stroke. 2020 Apr;51(4):1142-1149. doi: 10.1161/STROKEAHA.119.027396. Epub 2020 Mar 6. Stroke. 2020. PMID: 32138631 Clinical Trial.
Dosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Pharmacokinetics Trial in Healthy Adult Volunteers.
Yendewa GA, Griffiss JM, Gray WA, Healen A, Proskin HM, Fulton SA, O'Riordan MA, Hoppel C, Blumer JL, Salata RA. Yendewa GA, et al. Among authors: proskin hm. Antibiotics (Basel). 2022 Apr 6;11(4):490. doi: 10.3390/antibiotics11040490. Antibiotics (Basel). 2022. PMID: 35453240 Free PMC article.
Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6.
DeCory HH, Sanfilippo CM, Proskin HM, Blondeau JM. DeCory HH, et al. Among authors: proskin hm. PLoS One. 2020 Aug 25;15(8):e0237603. doi: 10.1371/journal.pone.0237603. eCollection 2020. PLoS One. 2020. PMID: 32841261 Free PMC article. Clinical Trial.
A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation.
Yendewa GA, Griffiss JM, Jacobs MR, Fulton SA, O'Riordan MA, Gray WA, Proskin HM, Winkle P, Salata RA. Yendewa GA, et al. Among authors: proskin hm. J Glob Antimicrob Resist. 2020 Jun;21:171-180. doi: 10.1016/j.jgar.2019.09.017. Epub 2019 Oct 7. J Glob Antimicrob Resist. 2020. PMID: 31600598 Free PMC article. Clinical Trial.
57 results